FDA Reviews Diabetic And HIV Medications
The U.S. Food and Drug Administration has announced safety reviews of the FDA-approved medications Regranex Gel, Ziagen and Videx. via The Post Chronicle
May Zhou’s case closed
“There are some differences in the two findings”
Santa Rosa police said today that the conclusion of a 15-month investigation still points to suicide as the cause of the death of Stanford graduate student May Zhou. via ABC7 - KGO-TV/DT
Possible Case: Singulair
FDA reviewing cases of suicide linked to Singulair usage.
A Ton Of Bitter Melon Produces Sweet Results For Diabetes
“By isolating the compounds we believe to be therapeutic, we can investigate how they work together in our cells.”
Teams from the Garvan Institute of Medical Research and the Shanghai Institute of Materia Medica pulped roughly a tonne of fresh bitter melon and extracted four very promising bioactive components. via Science Daily
Total Body Formula, Total Body Mega Formula
Recall of liquid dietary supplement products, after reports of severe adverse reactions, including significant hair loss, muscle cramps, diarrhea, joint pain and fatigue.
Smoking tortoise found in China
Strange. I wonder if he prefers menthol, or perhaps unfiltered Camels? Smoking tortoise found in China - Yahoo! News : “BEIJING - A tortoise that smokes and appears to be addicted to nicotine has been … via The Amateur Economist & Curmudgeon Blog
Medicines Australia Sets World-First in Transparency
DEAKIN, Australia, 28 March 2008 - Medicines
Australia today set a global precedent for the pharmaceutical
industry by publishing the details of medical education events held
or sponsored by its member companies.
The report shows that 14,633…
Discontinuation of Development of TAK-475, a Compound for Treatment of Hypercholesterolemia
OSAKA, Japan, March 28, 2008 — Takeda Pharmaceutical
Company Limited (“Takeda”) today announced
discontinuation of development of TAK-475 (lapaquistat acetate), an
investigational compound studied for the treatment…
Otsuka to Pay More than $4 Million to Resolve off-label Marketing Allegations Involving Abilify
WASHINGTON, March 27, 2008-Otsuka American Pharmaceutical Inc.,
the U.S. subsidiary of Japanese pharmaceutical manufacturer Otsuka
Pharmaceutical Co., Ltd., has agreed to pay more than $4 million to
resolve allegations that it marketed Abilify, an…
VaxGen and Raven Terminate Merger Agreement
SOUTH SAN FRANCISCO, Calif., March 28, 2008
/PRNewswire-FirstCall/ — VaxGen, Inc. , a biopharmaceutical
company, announced that the Company and Raven biotechnologies, inc.
have mutually agreed to terminate their merger agreement in light
of…